FibroBiologics, Inc. Common Stock (FBLG) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 10.05M |
| Enterprise Value | 7.56M |
| P/E Ratio | -0.17 |
| PEG Ratio | 0.24 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.83 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.28 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -2.29 |
| Return On Equity | -5.37 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -832,000 |
| EBITDA | -17.61M |
| Net Income | -18.65M |
| Diluted EPS | -8.35 |
| Total Cash | 3.52M |
| Total Cash/Share | 0.93 |
| Total Debt | 1.46M |
| Total Debt/Equity | 0.32 |
| Current Ratio | 2.64 |
| Book Value Per Share | 1.23 |
| 52-Week Change | -87.56 |
| 52-Week High | 9.6 |
| 52-Week Low | 0.62 |
| Moving Average 50 Days | 1.33 |
| Moving Average 200 Days | 2.58 |
| Average Volume | 211,465 |
| Shares Outstanding | 6.66M |
| % Held by Institutions | 7.55 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 30, 2026 |